Similar Papers

Paper Title
Journal
Date
Author
Lymphoproliferative disorders after liver transplantation
Véronique Leblond ... Sylvain Choquet
Journal of Hepatology | VOL. 40
Véronique Leblond, et. al.Véronique Leblond ... Sylvain Choquet
09 Apr 2004
IBCL-735 Sociodemographic Characteristics and Outcomes of Patients Hospitalized with Post-Transplant Lymphoproliferative Disorder in the Setting of Liver Transplant: A Nationwide Analysis From 2016 to 2020
Shahryar Khan ... Fahad Rahman
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
Shahryar Khan, et. al.Shahryar Khan ... Fahad Rahman
26 Aug 2024
II. Challenges in the management of post-transplant lymphoproliferative disorder.
Luca Nassi ... Gianluca Gaidano
Hematological oncology | VOL. Suppl 33 1
Luca Nassi, et. al.Luca Nassi ... Gianluca Gaidano
01 Jun 2015
Posttransplant Lymphoproliferative Disorder Following Kidney Transplant
Alicia K Morgans ... Donald E Tsai
American Journal of Kidney Diseases | VOL. 55
Alicia K Morgans, et. al.Alicia K Morgans ... Donald E Tsai
05 Dec 2009
View more papers

More From: Clinical Lymphoma, Myeloma and Leukemia

Paper Title
Journal
Date
Author
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
Andrew H Lipsky ... Nicole Lamanna
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Andrew H Lipsky, et. al.Andrew H Lipsky ... Nicole Lamanna
01 Dec 2024
Table of Contents
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
A phase I study of romidepsin in combination with gemcitabine, oxaliplatin, and dexamethasone in patients with relapsed or refractory aggressive lymphomas enriched for T-cell lymphomas.
Nicole Foley ... Neha Mehta-Shah
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Nicole Foley, et. al.Nicole Foley ... Neha Mehta-Shah
01 Dec 2024
Editorial Board
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.